Sclerosing polycystic adenosis arising in the parotid gland with trismus: a case report and literature review.

J Korean Assoc Oral Maxillofac Surg

Department of Oral and Maxillofacial surgery, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Korea.

Published: August 2022

Sclerosing polycystic adenosis (SPA) is a rare, asymptomatic disease that occurs mainly in the salivary glands. We report the case of a 51-year-old man who presented with trismus and pain upon mouth opening. Magnetic resonance imaging revealed a 2-cm mass located in the anterior portion of the left parotid gland. SPA was diagnosed based on histopathological examination of the surgical specimen. In pathologic findings, there was a well-circumscribed multicystic nodule in the parenchyma. Dense fibrosis and chronic non-specific inflammatory cells were observed in the stroma. In 13 previous reports on SPA, the most preferred treatment was superficial or total parotidectomy. This report suggests that simple excision of SPA preserves facial nerve function and facial volume.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433854PMC
http://dx.doi.org/10.5125/jkaoms.2022.48.4.237DOI Listing

Publication Analysis

Top Keywords

sclerosing polycystic
8
polycystic adenosis
8
parotid gland
8
adenosis arising
4
arising parotid
4
gland trismus
4
trismus case
4
case report
4
report literature
4
literature review
4

Similar Publications

NHD/PLOSL is an orphan disease characterized by progressive presenile dementia associated with recurrent fractures due to polycystic bone lesions. In this study, we generated the human induced pluripotent stem cell (hiPSC) line BIHi292-A from a 30-year-old women diagnosed with NHD/PLOSL, carrying two compound heterozygous frameshift mutations [c.313del (p.

View Article and Find Full Text PDF
Article Synopsis
  • Intraductal carcinoma (IDC) is a rare salivary gland tumor, and this report focuses on a unique case of apocrine IDC found in a 60-year-old male's parotid gland that showed unusual sebaceous-like features.
  • The tumor was characterized microscopically by a papillary growth pattern with apocrine cells and areas resembling sebaceous cells, alongside notable genetic mutations in the AKT1 and BRAF genes.
  • Understanding the characteristics of this IDC variant is crucial, as it is a slow-growing disease, and more research is needed to determine its classification and potential connection to other salivary gland tumors.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines the role of mutations in the TREM2 gene, previously linked to Nasu-Hakola disease, in three unrelated patients diagnosed with the behavioral variant of frontotemporal dementia (bvFTD).
  • Each patient was evaluated through various neurological, psychiatric, and cognitive assessments, revealing a correlation between specific TREM2 variants and bvFTD symptoms.
  • Although the patients showed some clinical similarities to Nasu-Hakola disease, they exhibited distinct characteristics, including differences in age of onset, neuroimaging results, and disease progression.
View Article and Find Full Text PDF

With the advancement of molecular testing and the routine use of immunohistochemical stains, salivary gland tumours previously categorized as adenoma or adenocarcinoma, not otherwise specified, are being reclassified with distinct diagnoses. Newly recognized benign entities include: sclerosing polycystic adenoma, keratocystoma, intercalated duct hyperplasia and adenoma, and striated duct adenoma. Newly recognized malignant salivary gland tumours include: microsecretory adenocarcinoma, sclerosing microcytic adenocarcinoma, and mucinous adenocarcinoma.

View Article and Find Full Text PDF

Background: Intraductal carcinoma (IDC) of the salivary glands is a confounding entity, our understanding of which continues to evolve. At least four forms have been elucidated based on histomorphology, immunophenotype, and molecular profile: (1) intercalated duct-like, S100/SOX10+ with frequent NCOA4::RET fusions; (2) oncocytic, S100/SOX10+ with TRIM33::RET, NCOA4::RET, and BRAF V600E; (3) apocrine, AR+ with PI3 kinase pathway mutations; and (4) mixed/hybrid intercalated duct-like/apocrine, with S100/SOX10+ and AR+ areas and frequent TRIM27::RET. The revelation that myoepithelial cells harbor the same fusion as luminal cells suggested that fusion-positive cases are not in situ carcinomas as previously believed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!